FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

413 letters match. Newest first.

  1. Dr. Gater’s Weight Loss & Wellness

    Dr. Gater’s Weight Loss & Wellness marketed compounded semaglutide and tirzepatide with false or misleading FDA-approval and generic-Ozempic claims.

    Medium
  2. Remedy Meds

    FDA warns Remedy Meds that its telehealth site misleadingly labels pharmacy-made semaglutide and tirzepatide with approved-drug comparisons.

    Low
  3. EA WORKS Limited Liability Company dba Trust Labs

    FDA warned Trust Labs it sold unapproved compounded retatrutide and made false FDA-approval claims for semaglutide and tirzepatide online.

    High risk
  4. Fancy Meds, LLC dba Fancy Meds

    FDA warns Fancy Meds that its compounded semaglutide and tirzepatide website claims are false or misleading.

    Low
  5. Matthew Stern, CEO MyStart Health LLC.

    FDA warns MyStart Health over 'Generic Ozempic' claims for compounded semaglutide.

    Low
  6. Elite Health Center

    FDA warned Elite Health Center that its website falsely implied compounded semaglutide was FDA-approved, making the drugs misbranded.

    Low
  7. Curex

    FDA warned Curex that its website ads for compounded semaglutide and tirzepatide are false or misleading.

    High risk
  8. Mericon Industries, Inc.

    Mericon Industries sold Florical and Meribin supplements with unapproved drug claims for osteoporosis and serious manufacturing and labeling failures.

    High risk
  9. Green Vitality dba Gr33n

    FDA warned Green Vitality dba Gr33n that its Jimerito Honey Eye Drops are an unapproved new drug sold with disease-treatment claims.

    High risk
  10. My Holistic Honey c/o Shenzhen Qanhai Wanb Express Supply Chain Co., LTD

    FDA warned My Holistic Honey that its honey eye drops are an unapproved new drug sold with drug claims.

    High risk
  11. Mel Honey US

    FDA warned Mel Honey US that its Jimerito (Melipona) Honey eye drops are an unapproved new drug.

    High risk
  12. Trew Balance

    FDA warned Trew Balance that its Trew Vision CBD Eye Drops are an unapproved new drug sold with disease-treatment claims.

    High risk
  13. Life Enthusiast Co-op

    FDA tells Life Enthusiast Co-op its three eye products sold online are unapproved new drugs.

    High risk
  14. Innate Healthcare Institute

    FDA warned Arizona clinic Innate Healthcare Institute for selling unapproved umbilical cord stem cells marketed to treat autism.

    High risk
  15. AlzClipp / UniUni

    FDA warns AlzClipp/UniUni that its AlzClipp nasal product is an unapproved new drug and misbranded with false FDA approval claims.

    High risk
  16. Everlaan Organics, Inc. dba Maple Organics

    FDA warns Maple Organics over OTC drug CGMP failures, unapproved new drugs, and misbranding.

    High risk
  17. IndulgeRx Brands, Inc

    FDA says IndulgeRx's FightBack nut butters are unapproved new drugs because website and label claims target cancer and disease.

    Medium
  18. 7Tabz Retail, LLC

    FDA says 7Tabz Retail sells unapproved 7-OH drug products online with drug-like claims.

    High risk
  19. Royal Diamond Imports, Inc.

    FDA warned Royal Diamond Imports that its Roxy 7-OH kratom tablets are unapproved new drugs and its kratom drink mix contains an unsafe food additive.

    High risk
  20. Hydroxie, LLC

    FDA warned Hydroxie, LLC that its 7-OH tablets, strips, shots, and drink mix are unapproved drugs and an unsafe food additive.

    High risk
  21. Dynamic Blending Specialists, Inc.

    FDA cited Dynamic Blending Specialists for manufacturing failures in OTC drugs and an unapproved, misbranded oral antiseptic.

    High risk
  22. M.O.M. Enterprises, LLC

    FDA warned M.O.M. Enterprises over adulterated, misbranded baby supplements and unapproved-drug claims for Gripe Water.

    High risk
  23. Nefeteri Wellness

    FDA says Nefeteri Wellness sells two unapproved colloidal silver vaginal gels promoted to treat infections.

    High risk
  24. Amish Origins Management, LLC

    FDA warned Amish Origins over manufacturing quality failures and unapproved or misbranded OTC pain relief and lip balm products.

    High risk
  25. Mother Earth Minerals, Inc.

    FDA warns Mother Earth Minerals that its Calcium, Magnesium and Silver are unapproved drugs with disease claims and lack quality controls.

    High risk
  26. Supreme Rejuvenation, LLC

    FDA warned Supreme Rejuvenation that its exosome products are unapproved new drugs and unlicensed biological products.

    High risk
  27. Skye Biologics Holdings LLC

    FDA warns Skye Biologics its umbilical cord-derived BioECM products are unapproved drugs and unlicensed biologics, made with serious manufacturing (CGMP) failures.

    High risk
  28. Ningbo Riway Industrial Co., Ltd.

    Ningbo Riway Industrial, an OTC drug maker in China, was cited for manufacturing-practice failures and unapproved antiseptic wipes.

    High risk
  29. Bailey’s Wellness, LLC dba Bailey’s CBD

    Bailey’s CBD markets CBD animal and human products with unapproved drug claims, including products for food-producing animals.

    High risk
  30. Kabana Skin Care

    FDA warned Kabana Skin Care that its "Kabana Body Wash +UV" is an unapproved, misbranded sunscreen drug sold without required FDA clearance.

    Medium
  31. TKTX Numbing Cream USA

    FDA warned TKTX Numbing Cream USA that its lidocaine numbing creams are unapproved and misbranded new drugs.

    High risk
  32. Mihon Corp. d/b/a VitalityVita and Boulla, LLC

    FDA warns Mihon Corp./Boulla that VitalityXtra, PeakMax, ZapMax and ZoomMax supplements contain hidden sildenafil and diclofenac and are unapproved, misbranded drugs.

    High risk
  33. Prime Vitality, Inc. dba Prime Peptides

    FDA warned Prime Peptides that its website sells Semaglutide and Retatrutide as unapproved new drugs for weight loss and diabetes.

    High risk
  34. Summit Research Peptides

    FDA warned Summit Research Peptides for selling unapproved semaglutide, retatrutide, cagrilintide, tirzepatide, and mazdutide with drug claims.

    High risk
  35. Veronvy

    FDA warned Veronvy that its Elily Veronvy weight-loss drops are unapproved new drugs and falsely labeled "FDA APPROVED."

    Medium
  36. Dr. Brite, LLC

    FDA cited Dr. Brite for manufacturing quality failures and selling unapproved, misbranded oral care and hand sanitizer drugs.

    High risk
  37. LCC Ltd.

    FDA warned LCC Ltd. over manufacturing-quality failures, contamination testing gaps, discarded lab data, and unapproved mouthwash drugs.

    High risk
  38. Multaler et Cie SAS

    FDA cites Multaler et Cie for manufacturing failures and unapproved sunscreen after April 2024 inspection.

    High risk
  39. Fancy Drops Beauty LLC

    FDA says Fancy Drops Beauty sells unapproved eye drops claimed to change eye color.

    High risk
  40. Supercore Products Group, Inc.

    FDA warns Supercore that Hard Steel and Gold Hard Steel Plus are unapproved, mislabeled drugs with hidden sildenafil; Hard Steel also has acetaminophen.

    High risk
  41. Little Moon Essentials, LLC

    FDA warns Little Moon Essentials over CGMP failures and unapproved topical analgesic drugs made in Dania Beach, Florida.

    High risk
  42. Far East Summit LLC

    FDA says Far East Summit sold herbal supplements as unapproved drugs and made them under serious manufacturing violations.

    High risk
  43. Aerosol and Liquid Packaging, Inc.

    FDA warns Aerosol and Liquid Packaging on CGMP failures and unapproved antiseptic spray claims.

    High risk
  44. Root Bioscience Brands, LLC dba Naternal

    FDA warned Naternal that its CBD oils, gummies, and pet hemp oil are unapproved drugs due to drug claims.

    High risk
  45. Regenerative Processing Plant, LLC

    FDA warns Regenerative Processing Plant over unapproved, misbranded Regener-Eyes eye drops and serious sterile manufacturing violations.

    High risk
  46. AnuMed International, LLC

    FDA warned AnuMed International about unapproved drugs, misleading FDA claims, and manufacturing quality failures.

    High risk
  47. Skin Beauty Solutions

    FDA warns Skin Beauty Solutions that its chemical peel products are unapproved new drugs sold with acne and scar treatment claims.

    High risk
  48. Amazon.com, Inc.

    FDA warns Amazon over selling two unapproved chemical peel drugs that can burn skin.

    High risk
  49. V10Suppliers.com

    FDA warned UK website V10Suppliers.com for selling unapproved, misbranded opioid drugs to U.S. consumers.

    High risk
  50. White Label Leaf, LLC/Flying Monkey US, LLC

    FDA warned Flying Monkey US that its Delta-8 THC gummies are adulterated food and are being sold as unapproved new drugs.

    High risk